DE1910561A1 - Hair loss prevention agents - Google Patents

Hair loss prevention agents

Info

Publication number
DE1910561A1
DE1910561A1 DE19691910561 DE1910561A DE1910561A1 DE 1910561 A1 DE1910561 A1 DE 1910561A1 DE 19691910561 DE19691910561 DE 19691910561 DE 1910561 A DE1910561 A DE 1910561A DE 1910561 A1 DE1910561 A1 DE 1910561A1
Authority
DE
Germany
Prior art keywords
hair loss
loss according
preventing
salts
exist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19691910561
Other languages
German (de)
Inventor
Herten Dr Med Kurt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HERTEN DR MED KURT
Original Assignee
HERTEN DR MED KURT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HERTEN DR MED KURT filed Critical HERTEN DR MED KURT
Priority to DE19691910561 priority Critical patent/DE1910561A1/en
Priority to FR7007313A priority patent/FR2060316A1/en
Priority to IT481470A priority patent/IT1036504B/en
Priority to BE746615D priority patent/BE746615A/en
Priority to NL7002875A priority patent/NL7002875A/xx
Publication of DE1910561A1 publication Critical patent/DE1910561A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

DIpI.-Ing. H. B. KAHLER - Dr. Irg. W. STARKDIpI.-Ing. H. B. KAHLER - Dr. Irg. W. STRONG

PATENTANWÄLTE -j Q -j Q C β A PATENTANWÄLTE -j Q -j QC β A

Krefeld - Moerser Straße \HO · Fernruf CO 21 51) 2 Oit- 69Krefeld - Moerser Straße \ HO · Fernruf CO 21 51) 2 Oit- 69

Datum: 28.2.1969Date: 28.2.1969

Unser Zeichen: o pt ccs UC Di?Our reference : o pt ccs UC Di?

In d.r*nlwo,t bitte ona.l»nIn dr * n lwo, t please on a .l »n

Ihr Zeichen:Your sign:

Dr. med. Kurt Herten, 415 Kreield, Jentgesallee 11 Mittel zur Verhütung von HaarausfallDr. med. Kurt Herten, 415 Kreield, Jentgesallee 11 Preparations for preventing hair loss

Die Erfindung bezieht sich auf ein Mittel zur Verhütung von Haarausxall.The invention relates to an agent for preventing Hair removal.

Die Ursache des allgemeinen Haarausfalles und der G-iatzenbiiduiig bei Männern und Frauen konnte bisher nicht ausreichend geklärt v/erden. Der bisherige Stand der 'Technik in der Verhütung des Haarausfalles stützt sich auf die Erfahrungstatsachen der Alterungserscheinungen, der meist örtlichen Begrenzung im Schädeldachbereich und der gelegentlichen Folge nach Stoffwechselbelastungen wie Schv/angerschaft, fieberhaften Erkrankungen, Vergiftungen oder Arzneimittelbehandlung.The cause of general hair loss and g-iatzenbiiduiig in men and women has so far not been adequately clarified. The current state of the art in contraception the hair loss is based on the facts of experience of the signs of aging, the mostly local limitation in the roof of the skull and the occasional consequence of metabolic stress such as pregnancy, feverish Illness, poisoning, or drug treatment.

Ausgehend von diesen Erfahrungen wurde versucht, den Haarausfall durch Stoffwechselverbesserungen des Haarbodens mit Sexualhormonen, Schiladrüsenhormonen, Vitaminen und Extrakten pflanzlicher Herkunft zu verhüten. Man hat auch schon versucht, mit einem örtlichen Angebot von Aulbaustoffen, besonders Aminosäuren und deren Abkömmlingen, dein Haarausfall zuBased on these experiences, attempts were made to reduce hair loss by using metabolic improvements in the scalp To prevent sex hormones, shila gland hormones, vitamins and extracts of vegetable origin. One has already tried with a local supply of building materials, especially amino acids and their derivatives, to prevent your hair loss

009837/2185 Bad original009837/2185 original bathroom

Deutsche Bank AG 1O3/1525 Krefeld · Stadt-Sparkasse Krefeld 3O5 722 - Postscheck Essen 4O55Deutsche Bank AG 1O3 / 1525 Krefeld · Stadt-Sparkasse Krefeld 3O5 722 - Postal check Essen 4O55

begegnen. Schließlich sind auch kapillarerweiternde Mittel verwendet worden. Allgemein befriedigende und sichere Erfolge sind bishex- jedoch nicht erzielt worden.to encounter. Finally, there are also capillary dilators been used. Generally satisfactory and certain successes have not yet been achieved.

Diese Überlegungen,"* die zur Erfindung führen, gehen davon aus, daß mögliche Störfaktoren der Haarernahrung nur an der Kopfhaut zur Auswirkung kommen, infolge der ungünstigen anatomischen Lage bezüglich des Blutkreislauf es. Ais I'Olge tritt eine Verlangsamung der Gewebedurchspülung mit Serum und eine Durchlässigkeifcsverminderung der Zellwände der Koruhaut ein. Eine weitere Überlegung geht dahin, daß eine Weiterstellung (Hyperämie) der Kapillaren ein Absinken des inneren Wanddruckes im arteriellen und einem Anstieg im venösen Kapillax'bex'eich bewirkt. Dem loigx eine verminderte Abpressung von G-ewebeserum im arteriellen und eine verringerte liückilutung im venösen Kapiiiarbereich.These considerations, "* which lead to the invention, are based on this from that possible disruptive factors of the hair nutrition only at the Scalp come into play, as a result of the unfavorable anatomical Location related to the blood circulation it. Ais I'Olge kicks a slowing down of the tissue flushing with serum and a reduction in the permeability of the cell walls of the coral skin. Another consideration is that a continuation (Hyperemia) of the capillaries a decrease in the internal wall pressure in the arterial and an increase in the venous capillax'bex'eich causes. The loigx shows a reduced pressure of G-ewebeserum in the arterial and a reduced bleeding in the venous Capillary area.

Aus diesen Gründen könnten auch die bisherigen Maßnahmen zur Verhütung von Haarausfall, die auf eine Gei'äßerweiterung abzielten, keinen Erfolg haben. Nur eine vermehrte Durchsoülung des Gewebes mix Serum, das ja alle nötigen Sxoi-'e enthält sowie eine Wiederhersteilung der Zellvanddurchlässigkeit kann das Haar richtig ernähren.For these reasons, the previous measures to prevent hair loss, which aimed at dilatation of the blood vessels, could also have no success. Just an increased soaking of the tissue mix serum, which contains all the necessary Sxoi-'e as well as a restoration of the cell wall permeability nourishing the hair properly.

ITach diesen Erkenntnissen müssen deshalb kapiliarrisistenssteigernde bzw. kapillarabdichtende Mittel zur Anwendung kommen, unter Einhaltung eines normalen Kapillarkreislaufes. DieseAccording to these findings, therefore, capillary risk increasing or capillary sealing agents are used, while maintaining a normal capillary circuit. These

009837/2185009837/2185

badbath

sorgen für die Aufrechterhaltung des arteriellen Abpreßdruckes durch verminderte Durchlässigkeit für höhermolekulare Substanzen und Eiweiße.ensure that the arterial pressure is maintained through reduced permeability for higher molecular weight Substances and proteins.

Di e Erfindung schlägt deshalb alt' Mittel zur "Verhütung von Haarausfall eine Substanz vor, die im direkten Gegensatz zum Stande der Technik keine kapillarerweiternden sondern kapillarabdichtende Mittel enthält. Desweiteren soll das erfindungsgemäße Mittel Mineralsalze sowie calciummobilisierende Paktoren M wie z.P. Hebenschilddrüsenhormon oder Dihydrotachysterin aufweisen.The invention therefore proposes a substance for preventing hair loss which, in direct contrast to the state of the art, does not contain capillary-widening but capillary-sealing agents. Furthermore, the inventive agent should contain mineral salts and calcium-mobilizing factors M such as thyroid hormone or dihydrotachysterin.

Die neben den I'apillarabdichtungsmitteln der Substanz zugefügten Mineralsalze und calciuimnobilisierenden Paktoren dienen dazu, die Durchlässigkeit der Zellvände des Haarbodens für die Nährstoffe zu erhöhen.Those added to the substance in addition to the apillary sealants Mineral salts and calcium immobilizing factors serve to to increase the permeability of the cell walls of the scalp for nutrients.

Nach einem weiteren Merkmal der Erfindung ist vorgesehen, daßAccording to a further feature of the invention it is provided that

die Mineralsalze? aus Salzen des Calcium und/oder Kalium bestehen. ™ Gegebenenfalls können daneben auch Magnesiumsalze verwendet werden.the mineral salts? consist of salts of calcium and / or potassium. ™ If necessary, magnesium salts can also be used.

Schließlich sieht iie Erfindung vor, daß die Säurerestionen der f>alsr aup ualo?enionen und/oder PC,-Ionen und/oder SQ^- Ionen best^en.Finally, the invention provides that the acid residues of the f> alsr aup u alo? Enions and / or PC, ions and / or SQ ^ ions exist.

Die '"irkFarskeit des erfindungsgemäßen Kittels läßt sich weiterhin i?d\ir.%>: frhC:h =■£.,· -äaS dem T*ittel "το-ff-^echselentelfter ausThe '' irkFarskeit the coat according to the invention can furthermore i d \ ir%>:. FRHC. H = ■ £, · -äaS the T * edium "το-ff ^ echselentelfter from

00 9 8 337./;2 1 8 5.00 9 8 3 3 7. / ; 2 1 8 5.

V' ' ' ' BAD ORIGINAL V ' ''' BAD ORIGINAL

aus Methioninabkömmlingen, insbesondere Acethylmethionin zugesetzt wird.from methionine derivatives, especially acetyl methionine is added.

Nach einem weiteren Merkmal der Erfindung sollen in "bevorzugter Weise die Kapillarabdichtungsmittel aus Rutinabkömmlingen, insbesondere Trihydrooxaethylrutosidura oder aus HesperidinabkömmlIngen wie beispielsweise Hesperidinmythylchalkon bestehen.According to a further feature of the invention, "should be more preferred Make the capillary sealing means from rutin derivatives, in particular trihydrooxaethylrutosidura or from hesperidin derivatives such as hesperidin methyl chalcone exist.

Schließlich sieht die Erfindung vor, daß das Mittel in flüssiger Form hergestellt ist.Finally, the invention provides that the agent is produced in liquid form.

Ferner können dem Mittel haut^ffine Substanzen, insbesondere Glyzerin zum Transport des Mittels in tiefere Hautschichten zugesetzt sein.Furthermore, skin-affine substances, in particular Glycerine can be added to transport the agent into the deeper layers of the skin.

Beispiel; Zur Verhütung von weiterem Haarausfall wurden mehrere Patienten mit einem Mittel folgender Zusammensetzung behandelt: Example; To prevent further hair loss, several patients were treated with an agent of the following composition:

Nebenschilddrüsenhormon 20 Oollip EinheitenParathyroid hormone 20 oollip units

Kaliumchlorid 50,0 mgPotassium Chloride 50.0 mg

Magnesiumchlorid 38,1 mgMagnesium chloride 38.1 mg

Calciumchlorid - 44,4 mgCalcium chloride - 44.4 mg

d,l- Acethylmethionin 500,0 mgd, l-Acethyl methionine 500.0 mg

Trihydrooxyaethylrutosidum 500,0 mgTrihydrooxyaethylrutosidum 500.0 mg

aqua destillata 15,0 gaqua destillata 15.0 g

Glyzerin ad 50 gGlycerine ad 50 g

^erandlunp· erfol<?tp durch Auftragen des T-ittels auf die^ erandlunp · success <? tp by applying the title to the

009837/2 185009837/2 185

BAD ORIGINALBATH ORIGINAL

Kopfhaut j wobei regelmäßig sofort der Haarausfall gestoppt wurde. Gelegentlich sind v/eitere Behandlungen in Abständen von etwa Ή Tagen efforderlich gewesen.Scalp j being regularly stopped immediately the hair loss became. Further treatments at intervals of about 3/4 days have occasionally been necessary.

Claims (9)

^ 910561 Patentansprüche^ 910561 claims 1. Mittel zur Verhütung von Haarausfall,- dadurch gekennzeichnet, daß das Mittel Mineralsalze in Verbindung mit calciummobiüsierenden Faktoren, wie z.B. Nebenschilddrüsenhormon oder Dihydrotachysterin sowie Kapillärabdichtungsmittel r enthält.1. A composition for the prevention of hair loss, - characterized in that the agent contains mineral salts in conjunction with calciummobiüsierenden factors such as parathyroid hormone or Dihydrotachysterin and Kapillärabdichtungsmittel r. 2. Mittel zur Verhütung von Haarausfall nach Anspruch 1 ,-dadurch gekennzeichnet, daß die Mineralsalze aus Salzen des Calcium und/oder Kalium bestehen.2. Means for preventing hair loss according to claim 1, characterized in that the mineral salts are made from salts of the Calcium and / or potassium exist. j. Mittel zur Verhütung von Haarausfall nach Anspruch 2'j dadurch gekennzeichnet, daß neben Salzen des Calcium und/oder Kalium Magnesiumsalze vorhanden sind; j. Agent for preventing hair loss according to Claim 2'j, characterized in that, in addition to salts of calcium and / or potassium, magnesium salts are present; 4. Mittel zur Verhütung ύοπ Haarausfall nach einem der Ansprüche 1 bis 5, dadurch gekene-zeichnet,- daß die Säürerestioneii der Salze aus Haiogeniöilen tmd/oder PO--Ionen ünd/odei? SO ,-Ionen besteheni4. Means for preventing ύοπ hair loss according to one of claims 1 to 5, characterized in that - that the Säürerestioneii the salts from Haiogeniöilen tmd / or PO - ions ünd / odei? SO, ions exist 5. Mittel zur Verhütung von Haarausfall nach einem der MfcSpruche 1 bis 4j dadurch gekennzeichnet^ daß dem Mittel Stöffwecnse'lentgiiter zugesetzt sind;5. Means to prevent hair loss according to one of the MfcSpruche 1 to 4j characterized ^ that the means Stöffwecnse'lentgiiter are added; 6. Mittel zur Verhütung von Haarausfall nach liisprüch 5$ dadurch gekennzeichnet; daß der Stojifweehse±eiitgifter aus6. Means for preventing hair loss according to liisprüch 5 $ characterized; that the Stojifweehse ± eiitgifter from 37/218S37 / 218S BÄD QRIQiWALBÄD QRIQiWAL Methioninabkömmlingen, insbesondere Ace thy !.methionin besteht. 'Methionine derivatives, especially Ace thy! .Methionine consists. ' 7. Mittel zur Verhütung von Haarausfall nach einem der AnsOrüche 1 "bis 6, dadurch gekennzeichnet, daß die Kapillarabdichtungsmittel aus Rutinabkömmlingen, vorzugsweise Trihydrooxyaethylrutosidum bestehen.7. Means for preventing hair loss according to any of the Claims 1 "to 6, characterized in that the capillary sealing means from rutin derivatives, preferably Trihydrooxyaethylrutosidum exist. 8. Kittel zur Verhütung von Haarausfall nach einem der Ansprüche 1 bis 6, dadurch gekennzeichnet, daß die Eaplllara1;dichturu' aus 3Tespericlinabkcminlingen, insbesondere HesperidinmetlrTlchalkon bestehen.8. Coat the prevention of hair loss according to one of claims 1 to 6, characterized in that the Eaplllara1; dichturu '3 T espericlinabkcminlingen, particularly Hesperidinmetlr T lchalkon exist. 9. Mittel zur ""erhütung von Haarausfall nach einem Ansprüche 1 bis 3, dadurch grkennzeichnet, daß das Mittel in Π listiger Form hergestellt ist.9. Means for "preventing" hair loss after one Claims 1 to 3, characterized in that the agent in Π crafty form is made. 1O. Mittel zur Verhütung von Haarausfall nach einem oer Ansprüche 1 bos 9, dadurch gekennzeichnet, daß dem Mittel haut- 1 O. means for preventing hair loss according to one oer claims 1 bos 9, characterized in that the means skin g^ffne Substanzen, inabesondere Glyzerin zum Transport, des Mittels in tiefere Hautschichten zugesetzt sind.Open substances, especially glycerine for transport, des Means are added into deeper skin layers. 0 0 9 8 3 7/2185 BAD ORIGINAL0 0 9 8 3 7/2185 BAD ORIGINAL
DE19691910561 1969-03-01 1969-03-01 Hair loss prevention agents Pending DE1910561A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19691910561 DE1910561A1 (en) 1969-03-01 1969-03-01 Hair loss prevention agents
FR7007313A FR2060316A1 (en) 1969-03-01 1970-02-27 Hair loss prevention agent
IT481470A IT1036504B (en) 1969-03-01 1970-02-27 LOTION TO PREVENT HAIR LOSS
BE746615D BE746615A (en) 1969-03-01 1970-02-27 MEANS OF PREVENTING HAIR LOSS
NL7002875A NL7002875A (en) 1969-03-01 1970-02-27

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691910561 DE1910561A1 (en) 1969-03-01 1969-03-01 Hair loss prevention agents

Publications (1)

Publication Number Publication Date
DE1910561A1 true DE1910561A1 (en) 1970-09-10

Family

ID=5726863

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19691910561 Pending DE1910561A1 (en) 1969-03-01 1969-03-01 Hair loss prevention agents

Country Status (5)

Country Link
BE (1) BE746615A (en)
DE (1) DE1910561A1 (en)
FR (1) FR2060316A1 (en)
IT (1) IT1036504B (en)
NL (1) NL7002875A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216084A2 (en) * 1985-08-23 1987-04-01 Richardson-Vicks, Inc. Improved sunscreen and moisturizer
FR2604088A1 (en) * 1986-09-22 1988-03-25 Oreal PHOTOSTABLE COSMETIC COMPOSITION CONTAINING TRIHYDROXYETHYLRUTIN IN COMBINATION WITH WATER-SOLUBLE FILTERS DERIVED FROM BENZYLIDENECAMPHRE AND USE THEREOF FOR THE PROTECTION OF SKIN AND HAIR
EP0415598A1 (en) * 1989-08-16 1991-03-06 Unilever Plc Cosmetic composition
EP0461827A2 (en) * 1990-06-11 1991-12-18 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Hair restorer
FR2719468A1 (en) * 1994-05-05 1995-11-10 Oreal Cosmetic compositions based on certain bioflavonoids and uses in particular in the hair field.

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216084A2 (en) * 1985-08-23 1987-04-01 Richardson-Vicks, Inc. Improved sunscreen and moisturizer
EP0216084A3 (en) * 1985-08-23 1987-06-16 Charles Of The Ritz Group Ltd. Improved sunscreen and moisturizer
FR2604088A1 (en) * 1986-09-22 1988-03-25 Oreal PHOTOSTABLE COSMETIC COMPOSITION CONTAINING TRIHYDROXYETHYLRUTIN IN COMBINATION WITH WATER-SOLUBLE FILTERS DERIVED FROM BENZYLIDENECAMPHRE AND USE THEREOF FOR THE PROTECTION OF SKIN AND HAIR
FR2604089A1 (en) * 1986-09-22 1988-03-25 Oreal PHOTOSTABLE COSMETIC COMPOSITION CONTAINING ETHYLRUTIN DERIVATIVE AS PROTECTIVE AGENT AGAINST SOLAR LIGHT AND ITS USE FOR THE PROTECTION OF SKIN AND HAIR
BE1000404A3 (en) * 1986-09-22 1988-11-22 Oreal COSMETIC COMPOSITION CONTAINING photostable TRIHYDROXYETHYLRUTINE IN ASSOCIATION WITH FILTER HYDROSOLUBLE benzylidenecamphor DERIVATIVES AND USE FOR SKIN AND HAIR.
BE1000405A3 (en) * 1986-09-22 1988-11-22 Oreal COSMETIC COMPOSITION CONTAINING DERIVATIVE photostable ETHYLRUTINE AS AN AGENT OF PROTECTION FROM SUNLIGHT AND USE FOR SKIN PROTECTION AND HAIR.
US4837006A (en) * 1986-09-22 1989-06-06 L'oreal Photostable cosmetic composition containing trihydroxyethylrutin in combination with water-soluble sunscreens derived from benzylidenecamphor and its use in the protection of the skin and the hair
EP0415598A1 (en) * 1989-08-16 1991-03-06 Unilever Plc Cosmetic composition
EP0461827A2 (en) * 1990-06-11 1991-12-18 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Hair restorer
EP0461827A3 (en) * 1990-06-11 1994-01-05 Hayashibara Biochem Lab
FR2719468A1 (en) * 1994-05-05 1995-11-10 Oreal Cosmetic compositions based on certain bioflavonoids and uses in particular in the hair field.
EP0681827A1 (en) * 1994-05-05 1995-11-15 L'oreal Use of bioflavonoids as keratineous phaners protection agent
US5660818A (en) * 1994-05-05 1997-08-26 L'oreal Bioflavonoids as agents for protecting the physical and/or cosmetic properties of keratinous superficial body growths

Also Published As

Publication number Publication date
IT1036504B (en) 1979-10-30
FR2060316A1 (en) 1971-06-18
NL7002875A (en) 1970-09-03
BE746615A (en) 1970-07-31

Similar Documents

Publication Publication Date Title
Safar et al. Emergency cardiopulmonary bypass for resuscitation from prolonged cardiac arrest
RU2350313C2 (en) Composition for skin care, intended for local application
DE1910561A1 (en) Hair loss prevention agents
DE3751761T2 (en) Penetration enhancer for the transdermal administration of systemically active drugs
US5698206A (en) Topical composition for the treatment of spider veins
DE2934718A1 (en) SOLUTION FOR INTRAVENOUS ADMINISTRATION
WO2002063961B1 (en) Composition and methods for modulation of vascular structure and/or function
DE726075T1 (en) Non-inorganic pharmaceutical saline solutions for endonasal administration
DE4125400A1 (en) USE OF COLLAGEN FOR TREATING DEGENERATIVE JOINT PROCESSES
DE69735162T2 (en) L-CARNOSINE-CONTAINING AGENTS FOR THE TREATMENT OF KIDNEY LOSSES
DE69024053T2 (en) TREATMENT TO REDUCE EDM AND MUSCLE DAMAGE.
DE3937607A1 (en) USE OF AN ANTI-COAGULAR TREATMENT FOR TUMOR DISEASES
EP1485120B1 (en) Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constituents, for externally treating open, in particular chronic wounds
CH650678A5 (en) PHARMACEUTICAL AGENT FROM HUMAN INSULIN AND HUMAN PROINSULIN.
Haber et al. Sisters with familial benign chronic pemphigus (Gougerot, Hailey and Hailey)
DE3707999A1 (en) USE OF OXYPURINOL TO REDUCE CELL DAMAGE
EP0191214A2 (en) Purifying liquid cleanser comprising antiseptics
Stewart I6I
DE2139183A1 (en) Sustained action cosmetic and/or pharm compsns - contg addns of cyclic adenosine-monophosphoric acid
DE2729010A1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CELLULITE AND EXCESSIVE FAT
DE9219127U1 (en) Stabilized caloric nutrient solution and multi-chamber system for parenteral nutrition in humans
Culebras-Fernandez et al. Improvement of the nutritional condition with hypocaloric peripheral parenteral nutrition (HPPN) in the immediate postoperative period of elective abdominal surgery
EP0186258B1 (en) Lotion for blemished scin (comprising thymol)
DOTTER et al. The effects of specific gravity upon the distribution of intravascular contrast agents
Speckmann et al. Static elastic modulus of the turkey aorta